Imaging Characteristics of Normal Liver and Liver Tumors

Aug 14, 2017 by in ONCOLOGY Comments Off on Imaging Characteristics of Normal Liver and Liver Tumors

Ultrasound CT MRI Angiography – Hepatomegaly (early) – Irregular contour – Right lobe and medial left lobe atrophy; lateral left lobe and caudate lobe enlargement – Coarsened echotexture – Arteriovenous…

read more

Surgical Considerations

Aug 14, 2017 by in ONCOLOGY Comments Off on Surgical Considerations

Primary liver tumors  Hepatocellular carcinoma  Cholangiocarcinoma Hilar cholangiocarcinoma Gallbladder cancer Metastatic liver disease  Colorectal cancer  Neuroendocrine tumors  Non-colorectal non-neuroendocrine tumors The oncologic appropriateness of surgical resection varies according to the…

read more

Liver Anatomy and Function

Aug 14, 2017 by in ONCOLOGY Comments Off on Liver Anatomy and Function

Fig. 1.1 Schematic picture of the segments of the liver. The liver can be divided into eight segments based on first and second order divisions of the hepatic artery, portal vein,…

read more

Intrahepatic and Hilar Cholangiocarcinomas: Epidemiology, Basic Principles of Treatment, and Clinical Data

Aug 14, 2017 by in ONCOLOGY Comments Off on Intrahepatic and Hilar Cholangiocarcinomas: Epidemiology, Basic Principles of Treatment, and Clinical Data

Fig. 15.1 Cholangiocarcinoma classification: a Intrahepatic cholangiocarcinoma: tumors in the bile ducts within the hepatic parenchyma b Extrahepatic cholangiocarcinoma: tumors from the junction of the left and right hepatic ducts to…

read more

Multidisciplinary Model for Liver Tumors

Aug 14, 2017 by in ONCOLOGY Comments Off on Multidisciplinary Model for Liver Tumors

Time Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 7:30–11:30 CT: 07:30 Check-In 08:00 Scan CT: 07:50 Check-In 08:20 Scan Lab: 07:30 Lab: 08:00 Lab: 08:15…

read more

Radiation Therapy for Hepatocellular Carcinoma: Clinical Data

Aug 14, 2017 by in ONCOLOGY Comments Off on Radiation Therapy for Hepatocellular Carcinoma: Clinical Data

Authors Patients Tumor diameter/volume (tumor number) Dose/fraction size Objective response rate (%) Overall survival Toxicity ≥G3 (%) Ben-Josef et al. [11] 128 /Liver Malignancies – Median 60.75 Gy /1.5 Gy BID (40–90 Gy)…

read more
Get Clinical Tree app for offline access